Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 127

Similar articles for PubMed (Select 19901080)

1.

Key role of T cell defects in age-related vulnerability to West Nile virus.

Brien JD, Uhrlaub JL, Hirsch A, Wiley CA, Nikolich-Zugich J.

J Exp Med. 2009 Nov 23;206(12):2735-45. doi: 10.1084/jem.20090222. Epub 2009 Nov 9.

2.

CD40-CD40 ligand interactions promote trafficking of CD8+ T cells into the brain and protection against West Nile virus encephalitis.

Sitati E, McCandless EE, Klein RS, Diamond MS.

J Virol. 2007 Sep;81(18):9801-11. Epub 2007 Jul 11.

3.
4.

CD8(+) T cell-mediated immune responses in West Nile virus (Sarafend strain) encephalitis are independent of gamma interferon.

Wang Y, Lobigs M, Lee E, Koskinen A, Müllbacher A.

J Gen Virol. 2006 Dec;87(Pt 12):3599-609.

5.

CD8+ T cells use TRAIL to restrict West Nile virus pathogenesis by controlling infection in neurons.

Shrestha B, Pinto AK, Green S, Bosch I, Diamond MS.

J Virol. 2012 Sep;86(17):8937-48. doi: 10.1128/JVI.00673-12. Epub 2012 Jun 27.

6.

Protective capacity and epitope specificity of CD8(+) T cells responding to lethal West Nile virus infection.

Brien JD, Uhrlaub JL, Nikolich-Zugich J.

Eur J Immunol. 2007 Jul;37(7):1855-63.

PMID:
17559175
7.

Single-chain HLA-A2 MHC trimers that incorporate an immundominant peptide elicit protective T cell immunity against lethal West Nile virus infection.

Kim S, Li L, McMurtrey CP, Hildebrand WH, Weidanz JA, Gillanders WE, Diamond MS, Hansen TH.

J Immunol. 2010 Apr 15;184(8):4423-30. doi: 10.4049/jimmunol.0903955. Epub 2010 Mar 8.

8.

Repeated in vivo stimulation of T and B cell responses in old mice generates protective immunity against lethal West Nile virus encephalitis.

Uhrlaub JL, Brien JD, Widman DG, Mason PW, Nikolich-Zugich J.

J Immunol. 2011 Apr 1;186(7):3882-91. doi: 10.4049/jimmunol.1002799. Epub 2011 Feb 21.

9.

High clonality of virus-specific T lymphocytes defined by TCR usage in the brains of mice infected with West Nile virus.

Kitaura K, Fujii Y, Hayasaka D, Matsutani T, Shirai K, Nagata N, Lim CK, Suzuki S, Takasaki T, Suzuki R, Kurane I.

J Immunol. 2011 Oct 15;187(8):3919-30. doi: 10.4049/jimmunol.1100442. Epub 2011 Sep 9.

10.

CD22 is required for protection against West Nile virus Infection.

Ma DY, Suthar MS, Kasahara S, Gale M Jr, Clark EA.

J Virol. 2013 Mar;87(6):3361-75. doi: 10.1128/JVI.02368-12. Epub 2013 Jan 9.

11.

Tumor necrosis factor alpha protects against lethal West Nile virus infection by promoting trafficking of mononuclear leukocytes into the central nervous system.

Shrestha B, Zhang B, Purtha WE, Klein RS, Diamond MS.

J Virol. 2008 Sep;82(18):8956-64. doi: 10.1128/JVI.01118-08. Epub 2008 Jul 16.

12.

Persistence of virus-specific immune responses in the central nervous system of mice after West Nile virus infection.

Stewart BS, Demarest VL, Wong SJ, Green S, Bernard KA.

BMC Immunol. 2011 Jan 20;12:6. doi: 10.1186/1471-2172-12-6.

13.

IL-1R1 signaling regulates CXCL12-mediated T cell localization and fate within the central nervous system during West Nile Virus encephalitis.

Durrant DM, Daniels BP, Klein RS.

J Immunol. 2014 Oct 15;193(8):4095-106. doi: 10.4049/jimmunol.1401192. Epub 2014 Sep 8.

PMID:
25200953
14.

CD4+ T-cell responses are required for clearance of West Nile virus from the central nervous system.

Sitati EM, Diamond MS.

J Virol. 2006 Dec;80(24):12060-9. Epub 2006 Oct 11.

15.

The memory T cell response to West Nile virus in symptomatic humans following natural infection is not influenced by age and is dominated by a restricted set of CD8+ T cell epitopes.

Parsons R, Lelic A, Hayes L, Carter A, Marshall L, Evelegh C, Drebot M, Andonova M, McMurtrey C, Hildebrand W, Loeb MB, Bramson JL.

J Immunol. 2008 Jul 15;181(2):1563-72.

16.

Antigen-specific cytotoxic T lymphocytes protect against lethal West Nile virus encephalitis.

Purtha WE, Myers N, Mitaksov V, Sitati E, Connolly J, Fremont DH, Hansen TH, Diamond MS.

Eur J Immunol. 2007 Jul;37(7):1845-54.

PMID:
17559174
17.

CD8+ T cells mediate recovery and immunopathology in West Nile virus encephalitis.

Wang Y, Lobigs M, Lee E, Müllbacher A.

J Virol. 2003 Dec;77(24):13323-34.

18.

A role for the chemokine RANTES in regulating CD8 T cell responses during chronic viral infection.

Crawford A, Angelosanto JM, Nadwodny KL, Blackburn SD, Wherry EJ.

PLoS Pathog. 2011 Jul;7(7):e1002098. doi: 10.1371/journal.ppat.1002098. Epub 2011 Jul 21.

19.

IPS-1 is essential for the control of West Nile virus infection and immunity.

Suthar MS, Ma DY, Thomas S, Lund JM, Zhang N, Daffis S, Rudensky AY, Bevan MJ, Clark EA, Kaja MK, Diamond MS, Gale M Jr.

PLoS Pathog. 2010 Feb 5;6(2):e1000757. doi: 10.1371/journal.ppat.1000757.

20.

Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection.

Glass WG, Lim JK, Cholera R, Pletnev AG, Gao JL, Murphy PM.

J Exp Med. 2005 Oct 17;202(8):1087-98.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk